The Department of Health and Social Services shall:
(1) Adopt regulations which prescribe minimum standards for manufacturers in preparing, compounding, processing or packaging laetrile (amygdalin, Vitamin B-17);
(2) Conduct inspections of manufacturers of laetrile (amygdalin, Vitamin B-17);
(3) Establish reasonable fees, to be collected from the manufacturer, for the purpose of paying the costs of the inspections.